TW200621785A - Analgesic - Google Patents

Analgesic

Info

Publication number
TW200621785A
TW200621785A TW094138512A TW94138512A TW200621785A TW 200621785 A TW200621785 A TW 200621785A TW 094138512 A TW094138512 A TW 094138512A TW 94138512 A TW94138512 A TW 94138512A TW 200621785 A TW200621785 A TW 200621785A
Authority
TW
Taiwan
Prior art keywords
provides
analgesic
present
various
subsitituent
Prior art date
Application number
TW094138512A
Other languages
English (en)
Chinese (zh)
Other versions
TWI356826B (enExample
Inventor
Naoki Izumimoto
Kuniaki Kawamura
Toshikazu Komagata
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Publication of TW200621785A publication Critical patent/TW200621785A/zh
Application granted granted Critical
Publication of TWI356826B publication Critical patent/TWI356826B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW094138512A 2004-11-04 2005-11-03 Analgesic TW200621785A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004320583 2004-11-04

Publications (2)

Publication Number Publication Date
TW200621785A true TW200621785A (en) 2006-07-01
TWI356826B TWI356826B (enExample) 2012-01-21

Family

ID=36319248

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094138512A TW200621785A (en) 2004-11-04 2005-11-03 Analgesic

Country Status (12)

Country Link
US (1) US8470845B2 (enExample)
EP (1) EP1820505A4 (enExample)
JP (1) JP4706636B2 (enExample)
KR (1) KR101285645B1 (enExample)
CN (1) CN101090722B (enExample)
AR (1) AR053098A1 (enExample)
CA (1) CA2586181C (enExample)
MX (1) MX2007005336A (enExample)
NO (1) NO20072832L (enExample)
PE (1) PE20060723A1 (enExample)
TW (1) TW200621785A (enExample)
WO (1) WO2006049248A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200806294A (en) * 2005-11-09 2008-02-01 Toray Industries Therapeutic or prophylactic agent for functional intestinal injury
CA2634055C (en) 2005-12-21 2011-07-05 Toray Industries, Inc. Antitussive agent
FR2902341B1 (fr) 2006-06-16 2011-02-25 Scras Utilisation therapeutique simultanee, separee ou etalee dans le temps d'au moins une neurotoxine botulique, et d'au moins un derive opiace
FR2910327B1 (fr) 2006-12-22 2013-04-26 Scras Utilisation d'au moins une neurotoxine botulique pour traiter la douleur induite par les traitements therapeutiques du virus du sida.
CA2687956C (en) * 2007-05-21 2015-03-31 Toray Industries, Inc. Method for producing pharmaceutical tablet
WO2008143240A1 (ja) * 2007-05-21 2008-11-27 Toray Industries, Inc. 特定の有機酸を含有する経口製剤並びに経口製剤の溶出性及び化学的安定性の改善方法
JP5564943B2 (ja) * 2007-05-21 2014-08-06 東レ株式会社 結晶性微粉化粒子
FR2930447B1 (fr) 2008-04-25 2010-07-30 Sod Conseils Rech Applic Utilisation therapeutique d'au moins une neurotoxine botulique dans le traitement de la douleur dans le cas de la neuropathie diabetique
CA3091752A1 (en) 2018-03-08 2019-09-12 Victoria Link Ltd Treatment of demyelinating diseases

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4118823B1 (enExample) * 1964-02-03 1966-10-31
US3318886A (en) * 1965-07-21 1967-05-09 American Cyanamid Co Substituted 7-hydroxymethyl-7, 8-dihydro-6-amino-6, 14-endoethenocodides and morphide
NL8102558A (nl) * 1981-05-25 1982-12-16 Alcoa Nederland Bv Lichtmast met versterking van de opening in het onderste gedeelte.
JP2525552B2 (ja) * 1992-01-23 1996-08-21 東レ株式会社 モルヒナン誘導体および医薬用途
NZ268969A (en) 1993-07-23 1997-06-24 Toray Industries Morphinan derivatives and pharmaceutical compositions
JP3348230B2 (ja) 1995-03-03 2002-11-20 アルゴス ファーマシューティカル コーポレーション 尿失禁の治療用のデキシトルメトルファン又はデキシトルオルファンの使用
AU6020300A (en) 1999-07-19 2001-02-05 Toray Industries, Inc. Remedies or preventives for frequent urination or urinary incontinence
DE19939044A1 (de) * 1999-08-18 2001-03-15 Gruenenthal Gmbh Verwendung von Morphinanderivaten als Arzneimittel
ATE292625T1 (de) 2000-10-31 2005-04-15 Rensselaer Polytech Inst 8-substituierte 2,6-methano-3-benzazocine und 3- substituierte morphinane als opioidrezeptorbindende agenzien
CN100537573C (zh) * 2002-10-09 2009-09-09 东丽株式会社 尿频或尿失禁的治疗或预防剂以及具有含氮环状取代基的吗啡烷衍生物
JP4118824B2 (ja) 2004-02-24 2008-07-16 株式会社日立製作所 優先パケットの遅延を最小化するシェーピング装置
JP4118826B2 (ja) 2004-03-01 2008-07-16 リオン株式会社 補聴器用ケースなどの製造方法及びその装置
DE602005011113D1 (de) 2004-03-30 2009-01-02 Toray Industries Morphinanderivate als mittel gegen juckreiz

Also Published As

Publication number Publication date
KR20070085436A (ko) 2007-08-27
CN101090722A (zh) 2007-12-19
WO2006049248A1 (ja) 2006-05-11
CA2586181A1 (en) 2006-05-11
JPWO2006049248A1 (ja) 2008-08-07
EP1820505A1 (en) 2007-08-22
CA2586181C (en) 2012-11-27
EP1820505A4 (en) 2010-01-20
JP4706636B2 (ja) 2011-06-22
PE20060723A1 (es) 2006-08-29
HK1115808A1 (en) 2008-12-12
US20070299100A1 (en) 2007-12-27
NO20072832L (no) 2007-08-01
KR101285645B1 (ko) 2013-07-12
TWI356826B (enExample) 2012-01-21
US8470845B2 (en) 2013-06-25
MX2007005336A (es) 2007-06-25
CN101090722B (zh) 2011-12-21
AR053098A1 (es) 2007-04-25

Similar Documents

Publication Publication Date Title
TW200615266A (en) Organic compounds
UA84712C2 (en) N-substituted pyrazolyl-amidyl-benzimidazolyl c-kit inhibitors
TW200728307A (en) Novel spirochromanone derivatives
PH12014502721A1 (en) IMIDAZO[1,2-b] PYRIDAZINE DERIVATIVES AS KINASE INHIBITORS
TW200740776A (en) N-phenylbenzotriazolyl c-kit inhibitors
MY140638A (en) New heterocyclic compounds, which are active as inhibitors of beta-lactamases
EA200501936A1 (ru) Производные пиридо[2,1-a]изохинолина в качестве ингибиторов dpp-iv
WO2005110410A3 (en) Kinase inhibitors as therapeutic agents
WO2005075425A3 (en) Substituted bisarylurea derivatives as kinase inhibitors
IL157254A0 (en) N-substituted nonaryl-heterocyclic nmda/mr2b antagonists
TW200612958A (en) Substituted imidazole derivatives
WO2005021544A3 (en) N3-substituted imidazopyridine-derivatives as c-kit inhibitors
MX2010008818A (es) Derivado de bicicloamina.
UA83875C2 (ru) Производные хинолина для применения в качестве микобактериальных ингибиторов
MX2009008779A (es) Composicion farmacéutica que comprende derivado de pirazina y método para usar el derivado de pirazina en combinación.
MXPA06009475A (es) Derivados de quinazolina y usos terapeuticos de los mismos.
MY152885A (en) Medicament containing fluoroquinolones
TW200736229A (en) Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors
NO20080033L (no) Kinolinderivater som NK3-antagonister
MXPA05013151A (es) 3-fluoro-piperidinas como antagonistas de n-metil-d-aspartato/nr2b.
NO20072832L (no) Smertestillende middel
UA97348C2 (en) HETEROCYCLIC NF-kB INHIBITORS
TW200800951A (en) Substituted imidazole compounds as KSP inhibitors
TW200628153A (en) Novel compounds
MXPA04009421A (es) Compuestos de tiazol-2-ilimina como inhibidores de la pde-7.

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees